Jushi Holdings Updates Investor Presentation, Highlights Q3 Revenue and Growth Plans
Jushi Holdings reported Q3 2026 revenue of $70.5M, up 7.3% YoY, with adjusted EBITDA at $13.6M. The company highlighted growth plans in Virginia, Pennsylvania, and Ohio, including Virginia's expected adult-use sales start in July 2027. Jushi also secured DEA registrations and completed a $160M debt refinancing.
How this was made

The 30-second read
Why it matters
The Q3 update and DEA registrations provide fresh material that could move the stock.
Market read
First‑report of earnings‑like numbers and regulatory approval; likely to influence short‑term price action.
What to watch
Execution risk on the planned warehouse and store rollout could temper upside.
Background
Jushi Holdings is a U.S.-listed cannabis operator expanding into adult‑use markets.
Ticker impact
Jushi Holdings disclosed Q3 2026 revenue of $70.5M, a 7.3% YoY increase, and received DEA registrations for medical cannabis operations.
likely upward pressure as investors price in revenue growth and DEA approval
Revenue beat expectations and new DEA registrations reduce regulatory risk, supporting a price rally.
Market effects
May boost sentiment for the broader U.S. cannabis sector as a peer gains DEA clearance.
Potentially supports Virginia and Pennsylvania cannabis market outlook.
Limited to U.S. cannabis investors; no broader macro effect.
Counterpoint
If the market has already priced in the growth, the update may be a short‑term sell‑off.
Key entities
- companyJushi Holdings
U.S. cannabis operator (ticker JUSH).
